Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Amazon is Close to Launching it Own TV in the U.S.

-Business Insider https://www.businessinsider.com/amazon-close-to-launching-its-own-tv-in-the-us-2021-9?r=US&IR=T

byCharles Gross

September 2, 2021

1 minute read

-Business Insider

https://www.businessinsider.com/amazon-close-to-launching-its-own-tv-in-the-us-2021-9?r=US&IR=T

BMO Capital Maintains Outperform on Canadian Western Bank, Lowers Price Target to C$35

By Benzinga Newsdesk

Today, 10:21 AM

BMO Capital analyst Sohrab Movahedi maintains Canadian Western Bank (TSX:CWB) with a Outperform and lowers the price target from C$39.5 to C$35.

TSX:CWB

Revance Shares Plunge On FDA Response Letter For Frown Line Candidate

By Vandana Singh

Today, 10:21 AM

The FDA has issued a Complete Response Letter (CRL) regarding Revance Therapeutics Inc’s (NASDAQ:RVNC) marketing application for DaxibotulinumtoxinA for Injection for moderate…

RVNC

Legal
News

WWE’s Vince McMahon Settles With Ex-Wrestling Referee Who Accused Him Of Rape; Pact Averts Public Legal Fight As McMahon Pursues Possible WWE Sale; Ex-Wrestling Referee Claim Had Sought $11.75M From WWE Executive Chairman – WSJ

By Benzinga Newsdesk

Today, 10:21 AM

- Dow Jones Citing WSJ

WWE

JP Morgan Maintains Overweight on MYT Netherlands Parent, Lowers Price Target to $34

By Benzinga Newsdesk

Today, 10:21 AM

JP Morgan analyst Matthew Boss maintains MYT Netherlands Parent (NYSE:MYTE) with a Overweight and lowers the price target from $40 to $34.

MYTE

Amazon is Close to Launching it Own TV in the U.S.

Related Posts

BMO Capital Maintains Outperform on Canadian Western Bank, Lowers Price Target to C$35

Revance Shares Plunge On FDA Response Letter For Frown Line Candidate

WWE’s Vince McMahon Settles With Ex-Wrestling Referee Who Accused Him Of Rape; Pact Averts Public Legal Fight As McMahon Pursues Possible WWE Sale; Ex-Wrestling Referee Claim Had Sought $11.75M From WWE Executive Chairman – WSJ

JP Morgan Maintains Overweight on MYT Netherlands Parent, Lowers Price Target to $34